ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.7% of net sales.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
24/26/24	€2.500	0.00%	2,847
23/26/23	€2.500	+6.84%	6,147
22/26/22	€2.340	-2.50%	5,809
21/26/21	€2.400	+1.69%	2,969
20/26/20	€2.360	+0.85%	64,901

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Closed - Euronext Paris Other stock markets 09:25:00 24/07/2026 pm IST			5-day change	1st Jan Change
2.500 ^EUR	0.00%		+6.84%	-16.67%

23/07	French Court OKs ABL Diagnostics' Industrial Plan to Acquire Texcell	MT
02/07	Abl Diagnostics Société Anonyme Approves Dividend Distribution for Fiscal Year 2025, Payable on July 7, 2026	CI

Market Cap	4.02Cr 4.57Cr 3.74Cr 3.43Cr 6.44Cr 440.48Cr 6.54Cr 44Cr 17Cr 216.56Cr 17Cr 17Cr 748.75Cr	P/E 2024	123x	P/E 2025	50x
Enterprise Value	4.11Cr 4.68Cr 3.82Cr 3.51Cr 6.59Cr 450.71Cr 6.69Cr 45Cr 18Cr 221.58Cr 18Cr 17Cr 766.13Cr	EV / Sales 2024	70,98,474x	EV / Sales 2025	61,85,843x
Free-Float	6.2%	Yield 2024	2.03%	Yield 2025	3.67%

23/07	French Court OKs ABL Diagnostics' Industrial Plan to Acquire Texcell	MT
02/07	Abl Diagnostics Société Anonyme Approves Dividend Distribution for Fiscal Year 2025, Payable on July 7, 2026	CI
12/06	Abl Diagnostics Sa and Cdl Pharma Secure Multi-Year International Contract of Up to Eur 2.7 Million Through 2031	CI
12/06	ABL Diagnostics Signs Multi-year Contract to Provide Clinical Trial Services	MT
12/06	ABL Diagnostics Secures Multi-Year Contract with CDL Pharma
10/06	ABL Diagnostics Offers to Buy Texcell	MT
05/06	ABL divests block of ABL Diagnostics shares
02/06	ABL Diagnostics Société anonyme Provides Earnings Guidance for the Fiscal Year Ending December 31, 2026	CI
18/05	ABL Diagnostics Société anonyme Proposes Dividend for the Financial Year Ended December 31, 2025, Payable on July 7, 2026	CI
07/05	ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
14/11	Abl Diagnostics Appoints Eurobio Scientific as Exclusive Distributor for Its Vela Product Line in A Targeted Segment of the French Market	CI
02/25/02	ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2025	CI
06/25/06	ABL Diagnostics Société anonyme announced that it expects to receive funding from Alumni Capital Management	CI

23/07	ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL’s Operations	BU
22/07	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL	BU
15/07	ABL Diagnostics Informed that its Reference Shareholder ABL Has Crossed Below the 95% Threshold	BU
10/07	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL	BU
02/07	ABL Diagnostics – Approval of Dividend Distribution for Fiscal Year 2025	BU

ABL Diagnostics Share Price

Stocks

ABLD

FR001400AHX6

Medical Equipment, Supplies & Distribution

Valuation: ABL Diagnostics

Chart: ABL Diagnostics

Latest news : ABL Diagnostics

Press Releases: ABL Diagnostics

News in other languages: ABL Diagnostics

Quotes and Performance

Course Extremes

Managers and Directors: ABL Diagnostics

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

23/07	ABL Diagnostics désignée par le Tribunal de commerce d'Évry pour la reprise des activités de TEXCELL
22/07	ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL
15/07	L'actionnaire de référence d'ABL Diagnostics allège ses positions
15/07	ABL Diagnostics informée du franchissement à la baisse du seuil de 95 % par son actionnaire de référence ABL
13/07	ABL DIAGNOSTICS : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ S1 2026

1 week	+6.84%
Current month	-10.07%
1 month	+3.31%
6 months	-25.60%
Current year	-16.67%

1 week	2.18	2.54
1 month	2.18	2.96
Current year	2.12	5
1 year	2.12	5.45
3 years	2.12	9.7
5 years	1.99	26
10 years	1.28	26

Director	Title	Age	Since
Noemie Sadoun CHM	Chairman	-	-
Laure Raffaelli BRD	Director/Board Member	-	-
Deborah Szafir BRD	Director/Board Member	-	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
02/06/26	Advanced Biological Laboratories SA	Sell	Company	-57,692	0.3580%
27/05/26	Advanced Biological Laboratories SA	Sell	Company	-51,900	0.3221%
17/03/26	Advanced Biological Laboratories SA	Sell	Company	54,745	0.3397%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ABL DIAGNOSTICS	0.00%	+6.84%	-55.75%	-71.59%	4.57Cr
ABBOTT LABORATORIES	+2.29%	+2.36%	-17.97%	-10.09%	18TCr
MEDTRONIC PLC	+1.46%	+0.01%	-9.87%	-6.25%	11TCr
CENCORA, INC.	+1.58%	+0.65%	+6.69%	+61.86%	6.03TCr
HOYA CORPORATION	-1.13%	-2.60%	+26.37%	+54.76%	5.02TCr
BECTON, DICKINSON AND COMPANY	+2.22%	-1.14%	-14.85%	-44.15%	4.31TCr
MEDLINE INC.	+2.98%	-2.61%	-	-	3.28TCr
DEXCOM, INC.	+1.50%	-6.67%	-17.52%	-43.99%	2.76TCr
WEST PHARMACEUTICAL SERVICES, INC.	-7.67%	-8.39%	+17.59%	-12.73%	2.31TCr
STERIS PLC	+1.63%	-1.73%	-5.80%	-7.80%	2.09TCr
Average	+0.49%	-1.33%	-7.90%	-8.89%	5.44TCr
Weighted average by Cap.	+1.28%	-0.40%	-6.63%	+0.83%

	2024	2025
Net sales	5.87 6.68 5.46 5.01 9.41 643.55 9.56 64.82 25.32 316.39 25.09 24.55 1.09T	7.97 9.07 7.41 6.8 12.77 873.39 12.97 87.97 34.37 429.39 34.05 33.31 1.48T
Net income	3L 3L 3L 2L 5L 3.13Cr 5L 31.49L 12.3L 1.54Cr 12.19L 11.93L 5.31Cr	10L 11.23L 9L 8L 15.82L 11Cr 16.06L 1.09Cr 42.57L 5.32Cr 42.17L 41.26L 18Cr
Net Debt	20.24L 23.04L 18.82L 17.27L 32.45L 22Cr 32.95L 2.23Cr 87.32L 11Cr 86.5L 84.64L 38Cr	9L 10.62L 9L 8L 14.95L 10Cr 15.18L 1.03Cr 40.24L 5.03Cr 39.86L 39L 17Cr